Intravenous doses of a synthetic component of “good” cholesterol reduced artery disease in just six weeks in a small study with startlingly big implications for treating the nation’s No. 1 killer.
CHICAGO (AP) _ Intravenous doses of a synthetic component of ``good'' cholesterol reduced artery disease in just six weeks in a small study with startlingly big implications for treating the nation's ...
LOS ANGELES -- A Southern California doctor accused of poisoning her husband's tea with Drano has been charged. Now, we're hearing from both attorneys in the case as the defendant is expected in court ...
Parallels between the human heart and a toilet? Believe it. In a study sponsored by biotechnology company Esperion Therapeutics Inc. of Ann Arbor, Mich., researchers have discovered a sort of “liquid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results